The Association of the British Pharmaceutical Industry (ABPI)’s Post

We warmly welcome Professor Anthony Harnden on his new appointment as Chair for the Medicines and Healthcare products Regulatory Agency. Our industry stands ready to support him and the wider MHRA in continuing to deliver the highest UK quality and safety standards alongside timely patient access to new medicines and technologies. Read our full response here: https://lnkd.in/e5tWTDdR

📣 We are delighted to welcome Prof Anthony Harnden as the new MHRA Chair. Anthony brings with him a wealth of experience from across the healthcare sector and academia that will be invaluable when advising on the strategic direction of the Agency to protect and promote public health. More information on his start date will follow in due course. To read the full announcement, visit ➡️ https://bit.ly/4eGQdIq

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics